Pfizer Initiates Phase 3 Study of mRNA-Based Influenza Vaccine

Go back to Pfizer Initiates Phase 3 Study of mRNA-Based Influenza Vaccine
Pfizer Inc. (NYSE: PFE) Delayed: 26.17 --26.17 (-0%)
Previous Close $0.00    52 Week High $37.39 
Open $26.17    52 Week Low $28.25 
Day High $26.17    P/E 15.86 
Day Low $26.17    EPS $1.65 
Volume 39,960       

Pfizer Inc. (NYSE: PFE) Delayed: 26.17 --26.17 (-0%)
Previous Close $0.00    52 Week High $37.39 
Open $26.17    52 Week Low $28.25 
Day High $26.17    P/E 15.86 
Day Low $26.17    EPS $1.65 
Volume 39,960